NYSE:JHX

James Hardie Stock Falls 2.7% as Citigroup Downgrades Shares to Neutral

James Hardie Industries shares fell 2.7% to $25.39 after Citigroup downgraded the stock to Neutral from Buy.

The downgrade points to a more cautious view on the company’s near-term risk-reward profile, with investors likely focusing on softer housing and renovation demand, elevated interest rates and affordability pressures across key residential construction markets.

James Hardie is particularly exposed to repair, remodeling and new-home activity, meaning higher borrowing costs and weaker housing turnover can weigh on demand for fiber cement siding and other building products.

Investors may also be reassessing valuation after earlier expectations for housing recovery and margin improvement. With the rating now at Neutral, the market reaction suggests Citigroup’s more cautious stance added to concerns about the pace of demand recovery.

The 2.7% decline reflects that shift in sentiment, even as James Hardie continues to benefit from long-term trends favoring durable exterior building materials.
James Hardie Stock Jumps 7.5% After Analysts Raise Price Targets

James Hardie Industries (NYSE: JHX) shares jumped about 7.5% Friday after fresh analyst actions provided a bullish catalyst for the building-products company.

The strongest call came from Truist Financial, which raised its price target on James Hardie to $40 from $30 while maintaining a Buy rating. The new target implies substantial upside from the stock's prior price around $30.26.

Oppenheimer also initiated or updated its outlook with a $36 price target, adding to the positive analyst sentiment surrounding JHX.

Truist Raises JHX Price Target by 33%

Truist's move was particularly significant, representing a roughly 33% increase in its price objective from $30 to $40.

With JHX trading around $30.26 before Friday's rally, the $40 target represented approximately 32% potential upside from that level.

Oppenheimer's $36 target was also comfortably above the previous market price, implying roughly 19% upside.

The combination of two constructive analyst reports appears to have strengthened investor confidence and triggered increased buying in JHX shares.

Why Is JHX Stock Up 7.5% Today?

Friday's sharp move appears primarily connected to the positive analyst activity, particularly Truist's substantial target increase.

Price-target changes alone do not always generate large stock moves, but the magnitude of Truist's revision — combined with Oppenheimer setting a bullish $36 target — provided investors with a significantly higher valuation framework for James Hardie.

The rally also suggests the market is reassessing expectations for the stock following recent weakness. With both analysts' targets materially above the previous share price, investors appear to be responding to the prospect of a more favorable risk-reward profile.

After Friday's roughly 7.5% surge, however, part of the upside implied by those targets has already been captured. The next question for JHX investors will be whether upcoming operating results and the company's outlook can support the more optimistic valuation reflected in the new analyst targets.
James Hardie Edges Lower in Premarket as Housing Headwinds and Margin Compression Weigh on Outlook

James Hardie Industries slipped 0.61% in premarket trading today after the building products company reported full-year results that beat its own guidance but reflected a challenging housing environment, significant margin compression from the AZEK acquisition, and a cautious near-term outlook that gave investors little reason for enthusiasm.

Full-year net sales grew 25% to $4.84 billion, largely reflecting the consolidation of the AZEK acquisition rather than organic momentum. Organic net sales actually declined 2% for the year as housing markets fell mid-to-high single digits. Full-year adjusted EBITDA rose 17% to $1.27 billion, exceeding guidance, with an adjusted EBITDA margin of 26.2%. Net income, however, collapsed 75% to $104 million from $424 million a year ago, and adjusted diluted EPS fell 27% to $1.09, reflecting acquisition-related costs, amortization of intangibles and restructuring charges.

In the fourth quarter, net sales rose 45% to $1.40 billion, again driven primarily by AZEK. Organic net sales declined 1%. Adjusted EBITDA of $380.9 million exceeded guidance, but net income fell 35% to $28.5 million.

The Siding and Trim segment, the company's largest, saw organic net sales fall 7% in Q4 with single-family exterior volumes down mid-double digits, particularly in the Southeast, Western regions and Texas. The Deck, Rail and Accessories segment delivered adjusted EBITDA margin of 28.2% in the quarter but faces near-term inventory headwinds heading into Q1 fiscal 2027. Australia and New Zealand was the bright spot, with adjusted EBITDA margin expanding 130 basis points to 35.8%.

For fiscal 2027, the company guided for total net sales of $5.25 billion to $5.41 billion and total adjusted EBITDA of $1.45 billion to $1.50 billion, implying roughly 15% to 19% EBITDA growth. Free cash flow is expected to exceed $500 million, more than $200 million above fiscal 2026 levels, as integration costs roll off and synergies accelerate. Cost synergies are already ahead of the original three-year schedule toward a $125 million target.

The modest premarket decline reflects a market that acknowledges the execution discipline and synergy progress but remains cautious about organic volume recovery in a housing market where affordability pressures show no signs of easing quickly.
James Hardie (NYSE/ASX: JHX) reported Q3 FY26 net sales of $1.2 billion, up 30% year-over-year, with organic growth of 1%. Operating income was $176 million and adjusted EBITDA reached $330 million.

Siding & Trim sales rose 10% (+1% organic), with adjusted EBITDA margin expanding ~500 basis points sequentially. Deck, Rail & Accessories sales increased 2%, with mid-single-digit sell-through growth.

The company said integration and cost synergies are ahead of schedule, surpassing its FY26 goal and reinforcing confidence in achieving its $125 million cost synergy target.
James Hardie Industries plc (ASX / NYSE: JHX) announced it will release financial results for the third quarter of its 2026 fiscal year after the market closes in the United States on Tuesday, February 10th and before the market opens in Australia on Wednesday, February 11th. Following the release, the company will hold a conference call to discuss results.
AZEK to Be Acquired by James Hardie in Cash-and-Stock Merger Valued at $26.45 Per Share

On March 23, 2025, The AZEK Company Inc. announced it has entered into a definitive merger agreement with James Hardie Industries plc (JHX), under which JHX will acquire AZEK in a transaction valued at $26.45 in cash plus 1.0340 JHX shares for each AZEK share. The deal, structured as a cash-and-stock merger, will see AZEK become an indirect wholly owned subsidiary of JHX.

At the effective time of the merger, AZEK shareholders will receive the stated cash consideration and JHX shares, subject to applicable tax withholdings, in exchange for each outstanding share of AZEK Class A common stock. The transaction will be taxable to AZEK shareholders for U.S. federal income tax purposes.

The agreement also includes detailed provisions for converting outstanding AZEK equity awards into new awards under JHX’s equity programs, preserving existing terms where possible. Notably, equity held by directors will vest immediately and be paid out in cash and shares.

The combined company will benefit from expanded scale and complementary product lines in the building materials sector. The merger is subject to regulatory approvals, a majority shareholder vote by AZEK, and other customary closing conditions. Three current AZEK board members — Gary Hendrickson, Jesse Singh, and Howard Heckes — will join JHX’s board upon closing.

If AZEK terminates the agreement to accept a superior proposal, it will be obligated to pay a $272 million termination fee.

The merger is expected to close by March 2026, pending satisfaction of conditions. A joint proxy statement/prospectus will be filed with the SEC in the coming months.